Falantes, Jose F <br/><br/>
The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome.  [electronic resource] 

 -  Leukemia & lymphoma  08 2017 
 - 1893-1902 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.1080/10428194.2016.1267350  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Biomarkers<br/>Bone Marrow--pathology<br/>Cause of Death<br/>Comorbidity<br/>Female<br/>Humans<br/>Incidence<br/>Leukocyte Count<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--diagnosis<br/>Prevalence<br/>Prognosis<br/>Retrospective Studies<br/>Risk<br/>Survival Analysis<br/>Symptom Assessment